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The data presented in this article is related to the research article
entitled “ABCA1 and HDL3 are Required to Modulate Smooth Muscle
Cells Phenotypic Switch after Cholesterol Loading” (Castiglioni et al.,
2017) [1]. This data describes the characterization of the phenotypic
changes induced by cholesterol loading in smooth muscle cells
(SMCs) isolated from the aortae of C57BL/6 mice. Upon cholesterol
loading, there is a signiﬁcant and concentration-dependent
decrease in the expression of Acta2 and a parallel increase inMac-2,
and ATP binding cassette (ABC) transporters Abca1 and Abcg1.
Cholesterol incubation causes the transformation of SMCs into foam
cells with a 3-fold increase in cellular total cholesterol content and a
2.5-fold stimulation of the activity of the esterifying enzyme Acyl-
CoA:cholesterol acyltransferase (ACAT). The addition of the same
amount of cholesterol, either dissolved in ethanol or as lipoprotein
cholesterol (AcLDL or native LDL) only slightly induces the activity
of the enzyme ACAT, and does not cause the accumulation of lipid
droplets into SMCs. We describe also the knock down of ABCA1
expression by siRNA treatment in mouse smooth muscle cells.
& 2017 Published by Elsevier Inc. This is an open access article under
the CC BY license (http://creativecommons.org/licenses/by/4.0/).is an open access article under the CC BY license
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Dubject area Cell Biology
ore speciﬁc
subject areaMechanism of atherosclerosisype of data Graphs, ﬁgures
ow data was
acquiredMicroscope, Real time PCR (Applied Biosystem ABI7000), western blot analysis,
ACAT enzyme activity, gas liquid chromatographyata format Analyzed
xperimental
factorsSmooth muscle cells were isolated from the aorta of C56BL/6, wild type or ABCA1
knock out micexperimental
featuresReal time PCR and western blot analyses were performed on mouse smooth
muscle cells previously incubated with cholesterol complexed with methyl-beta-
cyclodextrinata source
locationMilan, Italyata accessibility Data is within this article.Value of the data
 This data describes the cholesterol-induced phenotypic changes in murine smooth muscle cells.
 Cholesterol loading downregulates the expression of smooth muscle cell markers, and increases the
expression of inﬂammation-related genes. In addition, cholesterol transforms smooth muscle cells
into foam cells and affects lipid metabolism.
 The present data gives insights on how deliver cholesterol to metabolically active intracellular lipid
pools, independently of lipoprotein receptor pathway.1. Data
This dataset extends and completes the data presented in the recently published article [1].
Cholesterol loading of smooth muscle cells (SMCs) isolated from the aortae of C57BL/6 mice causes a
signiﬁcant and concentration-dependent decrease in Acta2 mRNA levels (Fig. 1A) and an increase in
Mac-2, Abca1 and Abcg1 mRNA (up to 10-fold, 16-fold and 160-fold, respectively). The effects on
mRNAs are conﬁrmed by western blot analysis (Fig. 1B). Cholesterol incubation causes the transfor-
mation of SMCs into foam cells, with intracellular accumulation of lipid droplets (Oil Red O staining;
Fig. 2A). There is a 3-fold increase in cellular total cholesterol content, due to the accumulation of both
free and esteriﬁed cholesterol (Fig. 2B). The increased cellular esteriﬁed cholesterol content is caused
by a 2.5-fold stimulation of the activity of the esterifying enzyme ACAT that is completely blocked by
the addition of Sandoz 58-035, a speciﬁc ACAT inhibitor (Fig. 3A). The addition of the same amount of
cholesterol, either dissolved in ethanol or as lipoprotein cholesterol (native low-density lipoprotein
(LDL) or Acetylated LDL) slightly induces the activity of the ACAT enzyme (Fig. 3A), and does not cause
the accumulation of lipid droplets into SMCs (data not shown). The cholesterol delivered is available
for downloading in the presence of HDL3 (Fig. 3B).
As shown in Fig. 4, the incubation of WT SMC with Abca1 siRNA reduces Abca1 expression to the
levels observed in Abca1 KO cells, as measured by either qRT-PCR or western blot analysis (Fig. 4).
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2.1. Cell cultures
SMCs were isolated from the intimal-medial layer of aortae of littermate Abca1 WT and KO mice of
both sexes (The Jackson Lab, Bar Harbor, ME, USA). The mice, originally on a DBA background, have
been backcrossed into C57BL/6 mice for at least nine times. All mice were kept in accordance with
guidelines from Directive 2010/63/EU of the European Parliament on the protection of animals used
for scientiﬁc purposes and the Italian Ministry of Health and the local University of Milan ethics
committee approved the protocol. Mice were anesthetized with 2% isoﬂurane and killed by cervical
dislocation. Aorta was rapidly dissected from the aortic root to the iliac bifurcation and SMCs pre-
pared according to the procedure described by Ross [2].
Cells were grown in Dulbecco's modiﬁed Eagle's medium (DMEM) supplemented with 20% FCS.
The medium was changed every three days. SMC lineage was conﬁrmed by the presence of immu-
noreactivity for Acta2 in 4 99% of the cells. The experiments have been performed using 8 cell lines
isolated from different mice of both genotypes. Cells were used between the 4th and 10th passage.2.2. HDL3 isolation
HDL3 were isolated from the plasma of healthy normolipidemic volunteers by sequential pre-
parative ultracentrifugation [3].Fig. 1. Effects of cholesterol-loading on mRNA and protein expression in SMC. SMCs isolated from C57BL/6 mice were treated
with increasing concentrations of Chol:MβCD in DMEM 0.2% EFAF. After 48 h, total mRNA and proteins were extracted and
subjected to qRT-PCR (A) or Western blot analysis (B) for Acta2, Mac-2, Abca1, and Abcg1, as described in Materials and
Methods. Data are expressed as mean 7 SD of three experiments performed in triplicates.
Fig. 2. Cholesterol loading induces the accumulation of lipids in C57BL/6 SMCs. (A) Mouse SMCs were treated with Chol:MβCD
(50 μg/mL) in DMEM 0.2% EFAF. After 48 h cells were ﬁxed in 4% paraformaldehyde, stained with Oil Red O and light micro-
scopic images acquired (original magniﬁcation X80). (B) In another set of cells, cellular lipids were extracted and total, free and
esteriﬁed cholesterol measured as described in Materials and Methods (Control cells: total cholesterol 41.3 μg/mg cell prot, free
cholesterol 30.1 μg/mg cell prot, esteriﬁed cholesterol 11.2 μg/mg cell prot.). Data are expressed as mean 7 SD of three
experiments performed in triplicates.
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Cholesterol was delivered to cells by using a Chol:MβCD complex as ‘‘water-soluble cholesterol’’
containing E 50 mg of cholesterol/g solid (molar ratio, 1:6 cholesterol/MβCD, Sigma-Aldrich) [4,5].
All treatment concentrations involving Chol:MβCD were based on cholesterol weight. SMCs were
incubated with DMEM supplemented with 0.2% Essential Fatty Acid Free albumin alone or containing
Chol:MβCD (50 µg/ml) or HDL3 (100 µg/ml) or apoAI (35 µg/ml) for 48 h.2.4. Oil Red O staining
Cholesterol-loaded SMCs were ﬁxed for 30 min with 4% paraformaldehyde solution in PBS, stained
with Oil Red O for 4 h and counterstained with hematoxylin for other 5 min [6]. Cells were examined
with a light microscope (X80) and pictures of representative ﬁelds were taken.
Fig. 3. Effect of lipoprotein or non-lipoprotein cholesterol on cholesterol esteriﬁcation in murine SMCs. (A) C57BL/6 mice SMCs
were treated for 48 h with cholesterol (50 μg/mL) added as Chol:MβCD, dissolved in ethanol or as lipoproteins (AcLDL or LDL).
In the last 2h of incubation, 14C-oleic acid was added and cholesterol esteriﬁcation measured as described in Materials and
Methods. (B) SMCs were incubated with Chol:MβCD (50 μg/mL) in presence or absence of HDL3 (100 μg/mL). Data are expressed
as mean 7 SD of two experiments performed in triplicates.
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After cholesterol loading, 14C-oleic acid was added and cholesterol esteriﬁcation measured fol-
lowing the incorporation of labelled oleate into cellular cholesteryl esters [7].2.6. Extraction and analysis of cellular cholesterol
Cell lipids were extracted in hexane/isopropyl alcohol (3:2) containing BHT 0.01%. Free- and
esteriﬁed cholesterol were separated by HPTLC plates and quantiﬁed on a DANI 1000 gas liquid
chromatographer [8]. Results were normalized by protein content.2.7. mRNA and miRNA levels measurement
Total RNA was extracted by using the TRIZOL solution (Invitrogen) according to manufacturer's
protocol and reverse transcribed (Thermo Scientiﬁc). SYBR Green-based real time PCR was used to
measure mRNA or miRNA levels [9]. The primers used for speciﬁc mouse genes are listed in Table 1.2.8. siRNA treatment
Wild type SMCs were transfected for 24 h with Abca1 siRNA (ON-TARGETplus SMARTpool Mouse
Abca1, Dharmacon) or a nonsense strand of siRNA (scramble, ON-TARGETplus Non-Targeting pool,
Dharmacon), using INTERFERin siRNA transfection reagent (Polyplus). Then, cells were treated for 48
hours with Chol:MβCD (50 μg/mL) in presence or absence of HDL3 (100 μg/mL). Total mRNA was
extracted and subjected to qRT-PCR analysis.
Fig. 4. Effect of Abca1 siRNA treatment on Abca1 expression. WT SMCs were treated for 24 h with 10 nM Abca1 siRNA or a
nonsense strand of siRNA (scramble). Then cells were treated for 48 h with Chol:MβCD (50 μg/mL) in DMEM 0.2% EFAF in
presence or absence of HDL3 (100 μg/mL). Total mRNA and protein were extracted and subjected to qRT-PCR analysis or
western blot analysis for Abca1 as described in Material and Methods. Data are expressed as mean 7 SD of three experiments
performed in triplicates.
Table 1
Sequences of mouse primers.
Gene name Sequences Gene name Sequences
Abca1 FW 5′-AAAACCGCAGACATCCTTCAG-3′ Mac-2 FW 5′-TGGGCACAGTGAAACCCAAC-3′
RV 5′-CATACCGAAACTCGTTCACCC-3′ RV 5′-TCCTGCTTCGTGTTACACACA-3′
Abcg1 FW 5′-CCTTATCAATGGAATGCCCCG-3′ Myocd FW 5′- AAGGTCCATTCCAACTGCTC-3′
RV 5′-CTGCCTTCATCCTTCTCCTG-3′ RV 5′-CCATCTCTACTGCTGTCATCC-3′
Acta2 FW 5′-GTCCCAGACATCAGGGAGTAA-3′ Klf4 FW 5′-CTTTCCTGCCAGACCAGATG-3′
RV 5′-TCGGATACTTCAGCGTCAGGA-3′ RV 5′-GGTTTCTCGCCTGTGTGAGT-3′
Calponin FW 5′-TTGAGAGAAGGCAGGAACATC-3′
RV 5′-GTACCCAGTTTGGGATCATAGAG-3′
S. Castiglioni et al. / Data in Brief 16 (2018) 334–340 3392.9. Western blot
Mouse SMCs were processed for Western blotting as described [9]. The different proteins were
detected using the following primary antibodies: Abca1 (1:1000; Abcam), Abcg1 (1:500; Novus
Biologicals), Acta2 (1:10,000; Abcam), Mac-2 (1:1000: Abcam), β-actin (1:5000; Sigma-Aldrich),
S. Castiglioni et al. / Data in Brief 16 (2018) 334–340340α-tubulin (1.5000; Sigma-Aldrich). Quantiﬁcation was performed by densitometric analysis using the
Image Studio Lite software from Li-Cor Bioscience.
2.10. Statistical analysis
Data were expressed as means 7 SD. All experiments were repeated at least four-ﬁve times in
triplicates.Acknowledgements
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